Image
illustration
Venture Capital Acquisitions & Partnerships

TARA BIOSYSTEMS partners with Scipher Medicine

Wednesday 3 November, 2021
Body

The partnership is set to reduce target discovery and validation from years down to months. Scipher will use proprietary patient molecular data analyzed by its SpectraTM platform to identify novel drug targets. TARA Biosystems will progress selected targets in its BiowireTM II drug discovery platform for cardiac laminopathies.

Content